학술논문
Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity
Document Type
Article
Source
In European Journal of Cancer August 2018 99:37-48
Subject
Language
ISSN
0959-8049